Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: Identification of one pancreatic ghrelinoma

被引:85
作者
Corbetta, S
Peracchi, M
Cappiello, V
Lania, A
Lauri, E
Vago, L
Beck-Peccoz, P
Spada, A
机构
[1] Osped Maggiore, IRCCS, Inst Endocrine Sci, I-20122 Milan, Italy
[2] Osped Maggiore, IRCCS, Dept Med Sci, I-20122 Milan, Italy
[3] Univ Milan, Osped L Sacco, Dept Clin Sci, Pathol Unit, I-20122 Milan, Italy
关键词
D O I
10.1210/jc.2002-021842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ghrelin is a novel gastrointestinal hormone involved in several metabolic functions. Although the expression of ghrelin has been demonstrated in most gastrointestinal carcinoids and pancreatic tumors, the circulating levels of this peptide have been marginally assessed in patients with these disorders. We measured plasma ghrelin levels in 16 patients with gastrointestinal carcinoid ( 10 with midgut and 6 with gastric carcinoid), 24 patients with pancreatic tumor (8 with gastrinoma, 2 with insulinoma, 2 with vipoma, 1 with glucagonoma, and 11 with nonfunctioning tumor), and 35 healthy controls. Plasma ghrelin levels recorded in patients with gastroenteropancreatic tumors were similar to controls (mean +/- SE, 182.7 +/- 66.5 pM in patients vs. 329 +/- 32 pM in controls, P = not significant), and no significant difference between gastrointestinal and pancreatic, functioning and nonfunctioning, and metastatic and nonmetastatic tumors was observed. One patient with metastatic nonfunctioning pancreatic tumor had circulating ghrelin levels of 12,000 pM that were slightly reduced during chemotherapy and interferon therapy. Immunohistochemistry performed on peritoneal lesions showed an intense, focal cytoplasmic positivity for ghrelin. Despite the 50-fold increase in ghrelin concentrations, the patient had normal serum GH and IGF-I levels. In conclusion, the study showed that carcinoids and pancreatic tumors rarely cause ghrelin hypersecretion. However, in this series, 1 pancreatic ghrelinoma not associated with clinical features of acromegaly was identified.
引用
收藏
页码:3117 / 3120
页数:4
相关论文
共 24 条
[1]   Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans [J].
Ariyasu, H ;
Takaya, K ;
Tagami, T ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Suda, M ;
Koh, T ;
Natsui, K ;
Toyooka, S ;
Shirakami, G ;
Usui, T ;
Shimatsu, A ;
Doi, K ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4753-4758
[2]   Sensations induced by medium and long chain triglycerides: role of gastric tone and hormones [J].
Barbera, R ;
Peracchi, M ;
Brighenti, F ;
Cesana, B ;
Bianchi, PA ;
Basilisco, G .
GUT, 2000, 46 (01) :32-36
[3]   Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients [J].
Cappiello, V ;
Ronchi, C ;
Morpurgo, PS ;
Epaminonda, P ;
Arosio, M ;
Beck-Peccoz, P ;
Spada, A .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (02) :189-194
[4]   Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans [J].
Date, Y ;
Kojima, M ;
Hosoda, H ;
Sawaguchi, A ;
Mondal, MS ;
Suganuma, T ;
Matsukura, S ;
Kangawa, K ;
Nakazato, M .
ENDOCRINOLOGY, 2000, 141 (11) :4255-4261
[5]   Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion [J].
Date, Y ;
Nakazato, M ;
Hashiguchi, S ;
Dezaki, K ;
Mondal, MS ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Arima, T ;
Matsuo, H ;
Yada, T ;
Matsukura, S .
DIABETES, 2002, 51 (01) :124-129
[6]   A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control [J].
de la Cour, CD ;
Björkqvist, M ;
Sandvik, AK ;
Bakke, I ;
Zhao, CM ;
Chen, D ;
Håkanson, R .
REGULATORY PEPTIDES, 2001, 99 (2-3) :141-150
[7]   Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion [J].
Egido, EM ;
Rodríguez-Gallardo, J ;
Silvestre, RA ;
Marco, J .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (02) :241-244
[8]  
EZZAT S, 1993, CANCER, V71, P66, DOI 10.1002/1097-0142(19930101)71:1<66::AID-CNCR2820710112>3.0.CO
[9]  
2-U
[10]   Minireview:: Ghrelin and the regulation of energy balance -: A hypothalamic perspective [J].
Horvath, TL ;
Diano, S ;
Sotonyi, P ;
Heiman, M ;
Tschöp, M .
ENDOCRINOLOGY, 2001, 142 (10) :4163-4169